[Rare viral infections during immunosuppressive therapy: a "normal" side effect?].
The use of biologicals in the therapy of rheumatic diseases allows more effective treatment of patients with very active disease. Such regimens, however, can induce a more severe treatment-related immunosuppression and, as a consequence, opportunistic infections that are rarely seen with conventional immunosuppressive therapy appear to occur more frequently. The majority of these opportunistic infections are common viral infections which become latent and only cause severe disease if they are reactivated in a severely immunocompromised host. However, some of the newer biologicals, especially natalizumab, efalizumab or rituximab, appear to carry a special risk for the reactivation of JC polyoma virus manifesting as progressive multifocal leukoencephalopathy, a severe, untreatable and often fatal encephalitis. Therefore, such treatments should be used with caution in patients who have been or are being treated with combined immunosuppressive therapy including corticosteroids. Elderly patients are specifically at risk for this "normal" side effect.
Innere Abteilung, Kreisklinik Trostberg, Kliniken Südostbayern, Trostberg, Deutschland. thomas.glueck@kreisklinik-trostberg.de
T
T
Glück
D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000139:chemically induced* / Q000150:complications*; D012216:Rheumatic Diseases / Q000188:drug therapy; D014777:Virus Diseases / Q000139:chemically induced* / Q000150:complications*
D007166:Immunosuppressive Agents
Arthritis Rheum. 2007 Dec;56(12):3928-39
18050208
J Cutan Pathol. 2005 Aug;32(7):474-83
16008691
Autoimmun Rev. 2009 Jan;8(3):266-73
19022409
Br J Dermatol. 2008 Dec;159(6):1217-28
18945310
Clin Microbiol Rev. 2009 Apr;22(2):274-90, Table of Contents
19366915
Curr Opin Rheumatol. 2007 Nov;19(6):619-25
17917544
N Engl J Med. 2001 Oct 11;345(15):1098-104
11596589
Arthritis Rheum. 2004 Jul;50(7):2072-81
15248204
Drug Saf. 2010 Nov 1;33(11):969-83
20925435
Autoimmun Rev. 2008 Dec;8(2):144-6
18700172
J Rheumatol. 2005 Aug;32(8):1473-80
16078322
Arthritis Rheum. 2007 Jul;56(7):2116-28
17599729
Ann Rheum Dis. 2006 Aug;65(8):983-9
16627542